semaglutide and retinal detachment Global Study Links GLP-1 Drugs to Various Optic Nerve, AEs GLP-1 Drugs and Diabetic Eye

The SELECT trial, completed in 2023 with over 17,600 participants, showed a 20% reduction in cardiovascular events in patients with established cardiovascular disease and overweight or obesity without diabetes

Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer

PMCID: PMC6678841 Caraffi SG, Maini I, Ivanovski I, Pollazzon M, Giangiobbe S, Valli M, Rossi A, Sassi S, Faccioli S, Rocco MD, Magnani C, Campos-Xavier B, Unger S, Superti-Furga A, Garavelli L

Retatrutide 10mg $150 ethoxy)acetylamino]ethoxy}ethoxy)acetyl]-[Aib 8 ,Arg 34 ]human GLP-1(7-37) ) is one of the most widely studied long-acting GLP-1 receptor agonists in modern endocrinology research

James OHara is a family nurse practitioner who uses an integrative approach to health, combining lifestyle interventions, targeted supplementation, and prescription medications when appropriate